-
NIMML team awarded American College of Gastroenterology Presidential Poster of distinction for human clinical trial reporting the anti-inflammatory efficacy of conjugated linoleic acid in patients with Crohn’s disease
-
NIMML team awarded American College of Gastroenterology Presidential Poster of distinction for human clinical trial reporting the [...]
-
Immunoregulatory mechanisms of microRNAs during Clostridium difficile infection
-
Viladomiu Pujol, M., R. Hontecillas, K. Michalak, C. Philipson, E. Schiff, A. Carbo, P. Michalak, and J. Bassaganya-Riera, (2014) [...]
-
IL-17 mediated the anti-microbial actions of PPAR gamma blockade during EAEC infection
-
Philipson, C., R. Hontecillas, and J. Bassaganya-Riera (2013) IL-17 mediated the anti-microbial actions of PPAR gamma blockade during [...]
-
Modulation of mucosal immune responses to Clostridium difficile by probiotic bacteria
-
Viladomiu M., R. Hontecillas, M. Pedragosa, C. Philipson and J. Bassaganya-Riera (2013) Modulation of mucosal immune responses to [...]
-
Vitamin D receptor regulates mucosal immune responses to Clostridium difficile infection
-
Viladomiu, M., R. Hontecillas, M. Pedragosa, P. Michalak, K. Michalak, P. Lu and J. Bassaganya-Riera (2013) Vitamin D receptor [...]
-
IL-21 is required for maintaining mucosal Th1 and Th17 responses during Helicobacter pylori infection
-
Carbo, A., R. Hontecillas, M.K. Washignton, R. Chatuverdi, D. Olivares-Villagomez, K.T. Wilson, J. Bassaganya-Riera and H.S. Algood [...]
-
Pharmacokinetic and preclinical evaluation of amixicile, a novel inhibitor of Clostridium difficile
-
Hoffman, P.S., A. Marshall, I. Olekhnovich, C.A. Warren, R.L. Guerrant, T.L. Macdonald, R. Hontecillas, M. Viladomiu, and J. [...]
-
Pilot study of the effect of conjugated linoleic acid on the modulation of immune responses in patients with mild to moderately active Crohn’s disease
-
Isaacs, K.L., R. Hontecillas, W.T. Horne, M. Sandridge, H. Herfarth and J. Bassaganya-Riera (2011) Pilot study of the effect of [...]
-
VSL#3 and conjugated linoleic acid ameliorate colitis and inflammation-driven colorectal cancer
-
Viladomiu, M., M. Pedragosa, C. De Simone, R. Hontecillas and J. Bassaganya-Riera (2011) VSL#3 and conjugated linoleic acid ameliorate [...]
-
Modulation of mucosal effector and regulatory T cell responses by Helicobacter pylori
-
Carbo, A., M. Climent, K. Muite, M. Viladomiu, M. Pedragosa, I. Fonseca, M. Humedas, M. Humedas, P. Lu, W. T. Horne, R. Hontecillas, [...]
-
Nutritional Regulation of Mucosal Inflammation and Immunity
-
Bassaganya-Riera, J. (2009) Invited speaker; Nutritional Regulation of Mucosal Inflammation and Immunity. CGIBD Research Seminar at University of North Carolina, Chapel Hill, NC
-
Nutritional Modulation of IBD by CLA and n-3 PUFA
-
Bassaganya-Riera, J. (2009) Invited speaker; Nutritional Modulation of IBD by CLA and n-3 PUFA; ESPEN Annual Meeting, Austria, Vienna.
-
BioTherapeutics: A Nutraceutical Company
-
Bassaganya-Riera, J. (2008) Invited speaker; BioTherapeutics: A Nutraceutical Company. MidAtlantic Business Alliance, McLean, VA.
-
Nutritional Immune Modulation in Infectious Diseases
-
Bassaganya-Riera, J. (2008) Invited speaker; Nutritional Immune Modulation in Infectious Diseases. University of Virginia, Charlottesville, VA.
-
Nutritional modulation of inflammation-induced colorectal cancer
-
Bassaganya-Riera, J. (2008) Invited speaker; Nutritional modulation of inflammation-induced colorectal cancer; Texas A&M, College Station, TX
-
Symposium on Inflammation and Innate Immunity
-
Bassaganya-Riera, J. (2008) Invited facilitator by the Translational Science Institute at Wake Forest University. Symposium on Inflammation and Innate Immunity, Winston-Salem, NC.
-
Mechanisms of modulation of inflammation-induced colorectal cancer by CLA
-
Bassaganya-Riera, J. (2007) Invited speaker at the II International CLA Congress; Mechanisms of modulation of inflammation-induced colorectal cancer by CLA; Corsica, Italy.
-
Nutritional modulation of chronic inflammation
-
Bassaganya-Riera, J. (2007) Invited speaker; Nutritional modulation of chronic inflammation; Michigan State University, East Lansing, MI.
-
Nutritional modulation of mucosal immunity
-
Bassaganya-Riera, J. (2007) Invited speaker; Nutritional modulation of mucosal immunity; University of London, London, UK.
-
Nutritional modulation of inflammation and immunity
-
Bassaganya-Riera, J. (2007) Invited speaker in the Nutrition Seminar; Nutritional modulation of inflammation and immunity; University of Connecticut, Storrs, CT.
-
Phase III Placebo-Controlled, Randomized Clinical Trial with Synthetic Crohn's disease Patients to Evaluate Treatment Response
- Abedi, V., P. Lu, R. Hontecillas, M. Verma, G. Vess, C. Philipson, A. Carbo, A. Leber, N.T. Juni, S. Hoops, J. Bassaganya-Riera. Emerging Trends in Computational Biology, Bioinformatics, and Systems Biology – Systems & Applications. In Press: Elsevier/MK 2015.
-
Modeling exercises
- Abedi, V., S. Hoops, R. Hontecillas, A. Carbo, C. Philipson, M. Viladomiu, A. Leber, P. Lu, J. Bassaganya-Riera. Computational Immunology: Models and Tools. Elsevier 2015.
-
Multiscale Modeling: Concepts, Technologies, and Use Cases in Immunology
- Abedi, V., R. Hontecillas, A. Carbo, C. Philipson, S. Hoops, J. Bassaganya-Riera. Computational Immunology: Models and Tools. Elsevier 2015.
-
From Big Data Analytics and Network Inference to Systems Modeling
- Michalak, P., B.W. Sobral, V. Abedi, Y.B. Kim, X. Deng, C. Philipson, M. Viladomiu, P. Lu, K. Wendelsdorf, R. Hontecillas, J. Bassaganya-Riera. Computational Immunology: Models and Tools. Elsevier 2015.
-
Agent-Based Modeling and High Performance Computing
- Alam, M., V. Abedi, J. Bassaganya-Riera, K. Wendelsdorf, K. Bisset, X. Deng, S. Eubank, R. Hontecillas, S. Hoops, M. Marathe. Computational Immunology: Models and Tools. Elsevier 2015.
-
Ordinary Differential Equations (ODE) based Modeling
- Hoops, S., R. Hontecillas, V. Abedi, A. Leber, C. Philipson, A. Carbo, J. Bassaganya-Riera. Computational Immunology: Models and Tools. Elsevier 2015.
-
Immunoinformatics cybernfrastructure for modeling and analytics
- Hoops, S., B.W. Sobral, P. Michalak, V. Abedi, B. Kronsteiner, R. Hontecillas, M. Viladomiu, J. Bassaganya-Riera. Computational Immunology: Models and Tools. Elsevier 2015.
-
Use of Computational Modeling in Immunological Research
- Hontecillas, R., J. Bassaganya-Riera, C. Philipson, A. Leber, M. Viladomiu, A. Carbo, K. Wendelsdorf, S. Hoops. Computational Immunology: Models and Tools. Elsevier 2015.
-
Computational Modeling
- Bassaganya-Riera, J., R. Hontecillas, V. Abedi, A. Carbo, C. Philipson, S. Hoops. Computational Immunology: Models and Tools. Elsevier 2015.
-
Introduction to Computational Immunology
- Bassaganya-Riera, J., R. Hontecillas. Computational Immunology: Models and Tools. Elsevier 2015.
-
Modulation of CD8+ T cell Responses by Conjugated Linoleic Acid
- Bassaganya-Riera, J, R. Hontecillas. Advances in CLA Research. Champaign, IL: American Oil Chemists Society Press 2006.
-
Computational Immunology: Models, tools and approaches for systems immunology
- Bassaganya-Riera, J.. Elsevier 2015.
-
Literature mining and ontology mapping applied to big data
- Abedi V, M. Yeasin, R. Zand. Mining Big Data to Improve National Security. Elsevier 2015.
-
Supervised Learning with Artificial Neural Network in Modeling of Cell Differentiation Process
- Lu, P, V. Abedi, Y. Mei, R. Hontecillas, C. Philipson, S. Hoops, A. Carbo, J. Bassaganya-Riera,. Emerging Trends in Computational Biology, Bioinformatics, and Systems Biology (1st ed.). Burlington, Massachusetts: Morgan Kaufmann (an imprint of Elsevier) 2015. 1-18
-
Method of Using Punicic Acid to Enhance Immune Response and Prevent Metabolic Disorders.
- Bassaganya-Riera, J.
International Patent Application Serial No. PCT/US2005/001811 U.S. Patent No: 8,258,188
-
Method of Using Punicic Acid to Enhance Immune Response and Prevent Metabolic Disorders.
- Bassaganya-Riera, J.
European Patent Application Serial No. 05711709.5
-
Method of Using Punicic Acid to Enhance Immune Response and Prevent Metabolic Disorders.
- Bassaganya-Riera, J.
Chinese Patent Application Serial No. 2005800088789
-
Method of Using Catalpic Acid to Treat and Prevent Metabolic Disorders.
- Bassaganya-Riera, J.
U.S. Patent No: 7,687,544
-
Method of Using Abscisic Acid to Treat and Prevent Diabetes and Inflammation.
- Bassaganya-Riera, J., A.J. Guri, and R. Hontecillas
U.S. Patent No: 7,741,367.
-
Method of Using Abscisic Acid to Treat and Prevent Diseases and Disorders.
- Bassaganya-Riera, J., A.J. Guri, and R. Hontecillas
U.S. Patent No: 1,986,624.
-
Method of Using Abscisic Acid to Treat and Prevent Diabetes and Inflammation.
- Bassaganya-Riera, J., A.J. Guri, and R. Hontecillas
International Patent Application Serial No. PCT/US2007/003366
-
Method of Using Abscisic Acid to Treat and Prevent Diabetes and Inflammation.
- Bassaganya-Riera, J., A.J. Guri, and R. Hontecillas
European Patent Application Serial No. 07763254.5
-
Method of Using Catalpic Acid to Treat and Prevent Hyperinsulinemia.
- Bassaganya-Riera, J.
U.S. Patent No: 7,834,058
-
Method of Using Catalpic Acid to Dyslipidemia.
- Bassaganya-Riera, J.
U.S. Patent No: 8,084,500
-
Method of using Conjugated Linoleic Acid to Enhance Thymocyte Development.
- M. O’Shea and Bassaganya-Riera, J.
European Patent Application Serial No. 06250952.6
-
Method of using probiotic bacteria to prevent obesity and type 2 diabetes.
- Bassaganya-Riera, J., R. Hontecillas, MG Dominguez-Bello, B. Sobral
U.S. Provisional Patent Application No: 60/942,016.
-
Method of Using Nutraceuticals for Ameliorating Hypertension and Vascular Inflammation.
- Bassaganya-Riera, J., A.J. Guri, and R. Hontecillas
(08.094 VTIP Disclosure); U.S. Provisional Patent Application No: 61/095662. U.S. Patent Application No. 12/869,237.
-
Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy.
- Bassaganya-Riera, J., A.J. Guri, and R. Hontecillas
(09-070 VTIP Disclosure); U.S. Provisional Patent Application No: 61/147773. U.S. Patent Application No. 12/695,915; 13/905,888 & EU10736394.7
-
Method of synergistically enhancing the therapeutic efficacy and safety of medications through a combination therapy.
- Bassaganya-Riera, J., A.J. Guri, and R. Hontecillas
International Patent Application Serial No. PCT/US2010/022390.
-
Method of using ABA for preventing and treating gut inflammatory disorders.
- Bassaganya-Riera, J., A.J. Guri, and R. Hontecillas
(10-066 VTIP Disclosure). CIP Application No: 12/712,899; Issued 8,367,727
-
Method of using lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders.
- Bassaganya-Riera, J., P. Lu, and R. Hontecillas
(10-116 VTIP) Provisional Patent Application No: 61/331,086; U.S. Patent Application No. 13/100,795
-
Method of using lanthionine synthetase component C-like proteins as molecular targets for preventing and treating diseases and disorders.
- Bassaganya-Riera, J., P. Lu, and R. Hontecillas
(10-116 VTIP) PCT/US11/35185. Notice of Allowance 13/100,795 and EU 11778258.1
-
Method of Preventing and Treating Inflammatory Diseases and Disorders with Abscisic Acid.
- Bassaganya-Riera, J., A.J. Guri, and R. Hontecillas
(10-134 VTIP) Provisional Patent Application No: 61/348,326, International application number: PCT/US11/38063. Issue fee paid
-
Novel LANCL2-based Therapeutics.
- Bassaganya-Riera, J., A. Carbo, J. Cooper, R. Gandour, and R. Hontecillas
Provisional Patent Applications No: 62/068,322 & 62/101,164.